Galmed Pharmaceuticals
GLMD
$0.38
Share price
-4.97%
Change (1 day)
18.78%
Change (1 year)
Categories
Earnings for Galmed Pharmaceuticals (GLMD)
Earnings in 2023 (TTM): -$6.92 M
According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$6.92 M. In 2022 the company made an earning of -$17.87 M an increase over its 2021 earnings that were of -$32.47 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Galmed Pharmaceuticals from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$6.92 M | -61.31% |
| 2022 | -$17.87 M | -44.97% |
| 2021 | -$32.47 M | 12.85% |
| 2020 | -$28.78 M | 40.61% |
| 2019 | -$20.47 M | 109.19% |
| 2018 | -$9.79 M | -20.47% |
| 2017 | -$12.3 M | -27% |
| 2016 | -$16.85 M | 58.6% |
| 2015 | -$10.63 M | 16.7% |
| 2014 | -$9.11 M | -47.94% |
| 2013 | -$17.49 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Evoke Pharma
EVOK | -$7.3 M | 5.50% | 🇺🇸 USA |
 Endo International
ENDPQ | -$2.4 B | 34,505.32% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | -$23.25 M | 236.24% | 🇺🇸 USA |
 Catalent CTLT | -$1.21 B | 17,362.38% | 🇺🇸 USA |